EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Discoidin Domain Receptors in Tumor Biology and Immunology: Progression and Challenge

Heng Zhang, Wenlong Chen, Haitao Zhu, Hsiang-I Tsai iD

Biomolecules · 07.06.2025 · 15 (6) · 832

DOI: 10.3390/biom15060832 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 07.06.2025. Verfasst von Heng Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Imaging and Artificial Intelligence, Jiangsu University, Zhenjiang 212013, China. Hauptthemen laut MEDLINE: Neoplasms, Discoidin Domain Receptors. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 138 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jiangsu Province Natural Science Foundation for Excellent Young Scholars.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The onset and progression of tumors involve intricate, multifactorial processes. A key component in tumor evolution is the dynamic interaction between cancer cells and the extracellular matrix (ECM). Discoidin Domain Receptors (DDRs), a unique class of collagen-activated receptor tyrosine kinases, serve as critical mediators of cell-ECM communication. Recent studies have uncovered their significant roles in modulating diverse cancer-related processes, including immune responses, cell proliferation, apoptosis, differentiation, metabolic reprogramming, metastasis, and resistance to therapy. This review begins with an overview of the discovery, structural features, and canonical and non-canonical functions of DDRs. It then focuses on the reciprocal regulation between DDRs and collagen in the tumor microenvironment, highlighting how this interplay contributes to cancer progression. Furthermore, we explore the involvement of DDRs in reshaping the tumor immune microenvironment and their influence on various aspects of cancer cell biology. Finally, we summarize the current advances in therapeutic strategies targeting DDRs, offering insights into their potential as biomarkers and drug targets in cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsDiscoidin Domain ReceptorsHumansTumor MicroenvironmentAnimalsDisease ProgressionExtracellular MatrixSignal Transduction

Stichwörter der Autor:innen

DDR1DDR2immunitytumor metastasis

Substanzen

Discoidin Domain Receptors

Autor:innen und Institutionen

  • Institute of Medical Imaging and Artificial Intelligence, Jiangsu University, Zhenjiang 212013, China.

ORCID-Profile: Hsiang-I Tsai

Förderung

  • Jiangsu Province Natural Science Foundation for Excellent Young Scholars

Zitieren

APA

Zhang, H., Chen, W., Zhu, H., & Tsai, H. I. (2025). Discoidin Domain Receptors in Tumor Biology and Immunology: Progression and Challenge. Biomolecules, 15(6), 832. https://doi.org/10.3390/biom15060832

Vancouver

Zhang H, Chen W, Zhu H, Tsai HI. Discoidin Domain Receptors in Tumor Biology and Immunology: Progression and Challenge. Biomolecules. 2025;15(6):832. doi:10.3390/biom15060832

BibTeX
@article{Zhang2025,
  author = {Zhang, Heng and Chen, Wenlong and Zhu, Haitao and Tsai, Hsiang-I},
  title = {Discoidin Domain Receptors in Tumor Biology and Immunology: Progression and Challenge},
  journal = {Biomolecules},
  year = {2025},
  volume = {15},
  number = {6},
  pages = {832},
  doi = {10.3390/biom15060832}
}
Kostenlos starten →